Recent work has shown that various cancer cells have elevated mTOR activity due to upregulation of mTOR complex components, e.g., mTOR, RICTOR, RAPTOR, mSIN1, PRAS40, and DEPTOR [9–14]. This evidence concerns the gene RICTOR and cancer.